English

Choose language

Back

  • Deutsch

  • English

  • Español

  • Français

  • Polski

  • Русский

  • Українська


English

All Stocks Johnson&Johnson

15.65%
Growth potential
138.48 $
Price per 1 share
USD
2.75%
Dividend income
Johnson&Johnson sold in lots of 1 pc.
Enter the number of securities
-
+
Order price:
Brokerage commission:
Transfer commission:
For All You Love
Why invest in Johnson&Johnson?
  • Over 250 subsidiaries and child companies throughout the world
  • A leading medical equipment manufacturer
  • Included into Dow Jones Global Titans 50
  • Over $20B earnings in Q4 2019


1d
1w
1mo
6mths
All the time
Recommendations of the largest investment banks
UBS
Hold
160 $
28.04.2020
BofA/Merrill
Buy
175 $
22.04.2020
Citigroup
Buy
163 $
05.03.2020
Barclays
Hold
173 $
19.12.2019
Financial indicators
Capitalization
393.98B $
P / E
258.17
Profit
81.38B $
Net profit
51.68B $

The American holding Johnson & Johnson specializes in the manufacture of healthcare and hygiene products. It ranks first in the world's top of companies with the largest output of medical equipment. Founded in 1886 as a family business, the company was initially engaged in the manufacture of bandaging products. The shares were put up for sale in 1944, shortly after, a thriving corporation set after swallowing up its European and North American competitors. The Company aims for the transition to the environmentally-clean manufacturing. To achieve this, a number of factories have switched to solar energy. Moreover, Johnson & Johnson avoid using plastic packaging for liquid products wherever possible. The medical specialization of the holding still stands for oncology, immunology, infectious diseases, neurology, and psychiatry. Johnson & Johnson actively invests in these areas' development. The company's current capitalization hits $317 billion. The Johnson & Johnson corporation is comprised of over 250 companies; it owns rights to over 120 brands. Alex Gorski is the Company's Director General since 2012. At the beginning of the Noughties, he was working for the Company's rivals for a while, but afterward, he returned and was rather speedily promoted. The General Director's power is not absolute; in fact, the extended holding is managed by the Board of the Company. Shares of Johnson & Johnson are rated as stable, growing in value slowly but steadily though.

Receive ideas for profitable investments - faster than the market

We will be sending you a letter once a week with the most relevant information

Congratulations!

Now you will always be aware of which stocks are more profitable to invest in